Accenture PLC (ACN.N)

ACN.N on New York Stock Exchange

81.06USD
29 Aug 2014
Price Change (% chg)

$0.04 (+0.05%)
Prev Close
$81.02
Open
$81.32
Day's High
$81.32
Day's Low
$80.52
Volume
484,688
Avg. Vol
586,637
52-wk High
$85.87
52-wk Low
$69.79

ACN.N

Chart for ACN.N

About

Accenture plc (Accenture) is engaged in providing management consulting, technology and outsourcing services. The Company’s business is structured around five operating groups, which together consists of 19 industry groups serving clients in industries globally. The Company’s segment includes Communications, Media & Technology,... (more)

Overall

Beta: 1.21
Market Cap (Mil.): $54,399.52
Shares Outstanding (Mil.): 671.10
Dividend: 0.93
Yield (%): 2.29

Financials

  ACN.N Industry Sector
P/E (TTM): 19.11 18.86 24.77
EPS (TTM): 4.24 -- --
ROI: 36.44 8.66 7.85
ROE: 53.28 10.86 11.39
Search Stocks

UPDATE 2-China anti-trust regulator conducts new raids on Microsoft, Accenture

* Investigation for suspected anti-monopoly law violations

06 Aug 2014

China anti-trust regulator conducts new raids on Microsoft and partner Accenture

BEIJING - A Chinese anti-trust regulator conducted new raids on Microsoft Corp and partner in China Accenture PLC, the agency said on its website on Wednesday, after saying last week Microsoft is under investigation for anti-trust violations.

06 Aug 2014

China anti-trust regulator conducts new raids on Microsoft and partner Accenture

BEIJING, Aug 6 - A Chinese anti-trust regulator conducted new raids on Microsoft Corp and partner in China Accenture PLC, the agency said on its website on Wednesday, after saying last week Microsoft is under investigation for anti-trust violations.

06 Aug 2014

Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO - The Netherlands’ Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

06 Aug 2014

UPDATE 1-Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO, Aug 5 - The Netherlands' Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

06 Aug 2014

Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO - The Netherlands’ Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

05 Aug 2014

Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO, Aug 5 - The Netherlands' Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

05 Aug 2014

U.S. top court rejects Accenture trade secrets appeal

WASHINGTON, June 9 - The U.S. Supreme Court on Monday left in place a $44 million damages award that Wellogix Inc won against Accenture Plc over alleged trade secrets theft.

09 Jun 2014

Indian shares rise to record; state-run banks extend rally on new Basel deadline

* BSE index at record 22,363.97; NSE marks life high at 6,702.60 * Foreign investors buy Indian stocks worth about $3 bln in March * IT stocks gain after Accenture raises profit guidance By Abhishek Vishnoi MUMBAI, March 28 - Indian shares hit a record high for a fifth straight session on Friday as state-run lenders such as State Bank of India continued their recent rally after the central bank extended the deadline for implementing Basel III capital-raising rules.

28 Mar 2014

IT shares gain; Accenture raises profit guidance

Reuters Market Eye - India's software exporters gain after global rival Accenture Plc on Thursday raised its full-year profit forecast and the lower end of its revenue forecast.

28 Mar 2014

Earnings vs. Estimates

Search Stocks